Joint work with Nanomedicine institutional stakeholders
The non-profit organisation CLINAM Foundation is the leading partner organising this major conference on Nanomedicine in Europe and works in collaboration with the European Technology Platform on Nanomedicine (ETPN) and the European Medicines Agency (EMA). Further partners are the European Society for Nanomedicine (ESNAM) and the European Science Foundation (ESF).
ETPN’s focus on generating European projects and translational issues
The ETP Nanomedicine contributes to CLINAM 2011 by organising 3 of 23 sessions held during the conference. The emphasis is on European Policy and funding, industrial challenges and projects’ proposals for joint collaborative research:
- Strategic Vision, Future Joint Research and Translation of Results, Needs for Policy Initiatives for the Benefit of the Patient (24th May 2011 – 11:15)
- Industrial Perspectives of Nanomedicine 2011 – 2020: Round table with six representatives from academia and industry (24th May 2011 – 12:00)
- ETPN Flash Proposals Session: Presentation of ideas for collaborative research projects (25th May 2011 – 10:45)
About the European Technology Platform on Nanomedicine - ETPN
The ETPN was established in 2005 as a joint venture of the European Commission, large industrial companies, SMEs and academic research institutions to investigate and advance joint activities in the area of medical nanotechnology. The ETPN contributed to the set up of numerous European-funded projects. The aim is to reach an efficient translation of R&D results into innovative products and to set the dialog with European legislation and regulations authorities. The ETPN supports its members with the coordination of their joint research efforts and the improvement of communication between the European Commission and the European Member States.
For more information, the full programme and to register for CLINAM 2011 check: http://www.clinam.orgContact:
Virtual reality conference comes to Reutlingen
19.03.2018 | Fraunhofer-Institut für Arbeitswirtschaft und Organisation IAO
Ultrafast Wireless and Chip Design at the DATE Conference in Dresden
16.03.2018 | Technische Universität Dresden
An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in “Nature” that LHPP can also serve as a biomarker for the diagnosis and prognosis of liver cancer.
The incidence of liver cancer, also known as hepatocellular carcinoma, is steadily increasing. In the last twenty years, the number of cases has almost doubled...
In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.
Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...
Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.
They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...
A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.
In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...
19.03.2018 | Event News
16.03.2018 | Event News
13.03.2018 | Event News
22.03.2018 | Trade Fair News
22.03.2018 | Earth Sciences
22.03.2018 | Earth Sciences